Related Image: UC biology prof traces his roots to the first Earth Day |
(Date:1/7/2009)...already spurred public health officials to advise ...ing concern in a warmer world. , So suggests a p... Oecologia . , Sue Natali, a postdoctoral assoc...e paper,s lead author, compared mercury levels in ...bon dioxide to soil beneath trees in ambient air. ...
(Date:1/7/2009)...l issue of American Journal of Medical Genetics (... a comprehensive overview of the latest progress i...ity Disorder (ADHD). The issue covers major trends...erscoring how genetic studies of ADHD have evolved...netic origins. , ADHD is a complex condition wit...
(Date:1/7/2009)...sed to low temperatures develop more blood vessels...ore quickly, according to a new study from Karolin...o control blood vessel development in humans in or... of fat cells and their metabolism depend on oxyge...ulate the amount of body fat in order, for instan...
(Date:1/7/2009)... , A PhD thesis at the University of the Bas...e mutation that causes Fatal Familiar Insomnia (FF...try there is a high rate of carriers of this mutat...f Spain. , Fatal Familiar Insomnia (FFI) is o...ess than 100 cases described throughout the world....
Breaking Biology News(10 mins):To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3Studies examine genetic determinants of ADHD 2Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3Standard 26 Poors Announces Changes to U S Indices 22973 1Standard 26 Poors Announces Changes to U S Indices 22973 2Standard 26 Poors Announces Changes to U S Indices 22973 3Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 1Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 2Genmab Reaches Milestone in Ofatumumab Collaboration 2556 1Genmab Reaches Milestone in Ofatumumab Collaboration 2556 2Caffeine Could Stave Off Multiple Sclerosis 22968 1Caffeine Could Stave Off Multiple Sclerosis 22968 2(Date:1/8/2009)... SAN DIEGO, Jan. 8 Orex...y announced that the first of four Phase 3 trials ...naltrexone sustained release,(SR)/bupropion SR) m...wing a,significant reduction in body weight, impr...ductions in selected food craving measures. , ...
(Date:1/8/2009)... REDWOOD CITY, Calif., Jan. 8 Ace...hired Dr. Roman Skowronski as Vice President, Clin...ronski will be responsible for,development and ex...l input,and review of clinical development strate...pany,s Chief Medical Officer. , Prior to jo...
(Date:1/8/2009)... HUNTINGTON BEACH, California, and AMSTERDAM, Jan... molecular cancer diagnostics, today announced the...mpany,s new Chief Financial,Officer. , "Ku...nvaluable asset,",said Bernhard Sixt, Ph.D., Pres...nsive financial management experience in the high ...
(Date:1/8/2009)...ERDEEN PROVING GROUND, Md., Jan. 8 ... anthrax attacks that followed, Edgewood Chemical ...ring Laboratory (EBML) staff focuses on developing...rld demands for global accreditation, increased se...y control. , , "We continue to work towards con...
Breaking Biology Technology:Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7Agendia Appoints New Chief Financial Officer 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 3... A few years ago, a VC friend of mine (that had ...repeatedly about a concept that was gathering forc...ction, in this case, meaning the casting away of p...ened to him and agreed, I didn,t recognize this mo...ing. The problem, as recognized by a recent articl...
... The transition from Microsoft Windows XP to ...the cultural transition we,ve already made from We...ly coined the term Web 2.0 in 2004, the Internet ... he imagined: a place where people are. It has bec...where we collaborate with others. It has also beco...
... West Allis, Wis. - Merge Healthcare , a financ...formation management software, continued to revamp...Bowers to president of Merge Healthcare North Amer...y,s senior vice president of strategic business in... Kenneth D. Rardin. In his new position, Bowers wi...
... Madison, Wis. - Molly Jahn is a realist, and sh...has a realistic chance to lead the drive toward en...f the College of Agricultural and Life Sciences ...ahn believes Wisconsin can leverage existing econo...uels. , ,She,s well aware of criticism that Wiscon...
Other Biology Technology:The deconstruction of Big Pharma 2The deconstruction of Big Pharma 3The deconstruction of Big Pharma 4The deconstruction of Big Pharma 5The deconstruction of Big Pharma 6The deconstruction of Big Pharma 7The deconstruction of Big Pharma 8Making the transition from Web 2.0 to Web 2.007 2Making the transition from Web 2.0 to Web 2.007 3UW-Madison dean predicts bio-economy will fuel Wisconsin 2UW-Madison dean predicts bio-economy will fuel Wisconsin 3mCD-1 10 transcription reactions
Rabbits x 2 , Maintenance 112 days/each , Pre-immune bleed x1 /each , Immunizations/Boost injections x5 /each , Test bleed (app. 5 ml) x1 /each , Production bleed (25 ml blood =12 m
Mouse VCAM-1/CD106 MAb (Clone 112702)
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*
Biology Products: